Suppr超能文献

血小板细胞骨架包含凝血酶原酶复合物的成分。

The platelet cytoskeleton contains elements of the prothrombinase complex.

作者信息

Tuszynski G P, Mauco G P, Koshy A, Schick P K, Walsh P N

出版信息

J Biol Chem. 1984 Jun 10;259(11):6947-51.

PMID:6539331
Abstract

Triton-insoluble cytoskeletons prepared from thrombin-activated platelets were found to potentiate the activation of prothrombin (prothrombinase activity). Cytoskeletons prepared from red cells or lymphoblasts contained no prothrombinase activity. The platelet prothrombinase activity was dependent on cytoskeletal-associated Factor Va, and exogenously added Factor Xa and prothrombin. Cytoskeletons contained 38% of the total platelet prothrombinase activity. Both platelets and cytoskeletons displayed half-maximal activities at similar prothrombin concentrations. The role of lipids in the cytoskeletal prothrombinase activity was investigated. Cytoskeletons were found to contain 3.8% of the total platelet phospholipids, consisting of the following lipids expressed as percentage of total present in platelets: 6.0% sphingomyelin, 3.8% phosphatidylcholine, 2.9% phosphatidyl-ethanolamine, 4.4% phosphatidylinositol, and 2.2% phosphatidylserine. The cytoskeletal prothrombinase activity and the lipid phosphorus content of cytoskeletons decreased after treatment of cytoskeletons with various doses of phospholipase C. Incubation of cytoskeletons with the highest concentrations tested (10 micrograms/ml) resulted in a 72% loss of phosphatidylserine and 84% loss of cytoskeletal prothrombinase activity. Cytoskeletal prothrombinase activity destroyed by phospholipase C treatment could be restored to control levels by treatment of hydrolyzed cytoskeletons with total cytoskeletal lipid or mixtures of phosphatidylserine/phosphatidylcholine (25:75% by weight). These results suggest that the cytoskeletal prothrombinase complex in addition to containing Factor Va, as has been previously shown (15), contains a lipid cofactor activity consisting in part of phosphatidylserine.

摘要

研究发现,从凝血酶激活的血小板中制备的不溶于曲拉通的细胞骨架能增强凝血酶原的激活作用(凝血酶原酶活性)。从红细胞或淋巴母细胞中制备的细胞骨架则不含有凝血酶原酶活性。血小板凝血酶原酶活性依赖于与细胞骨架相关的因子Va、外源添加的因子Xa和凝血酶原。细胞骨架含有血小板总凝血酶原酶活性的38%。血小板和细胞骨架在相似的凝血酶原浓度下均表现出半数最大活性。研究了脂质在细胞骨架凝血酶原酶活性中的作用。结果发现,细胞骨架含有血小板总磷脂的3.8%,其组成脂质占血小板中脂质总量的百分比分别为:鞘磷脂6.0%、磷脂酰胆碱3.8%、磷脂酰乙醇胺2.9%、磷脂酰肌醇4.4%和磷脂酰丝氨酸2.2%。用不同剂量的磷脂酶C处理细胞骨架后,细胞骨架凝血酶原酶活性和细胞骨架的脂质磷含量均降低。用最高测试浓度(10微克/毫升)孵育细胞骨架,导致磷脂酰丝氨酸损失72%,细胞骨架凝血酶原酶活性损失84%。经磷脂酶C处理而被破坏的细胞骨架凝血酶原酶活性,可通过用细胞骨架总脂质或磷脂酰丝氨酸/磷脂酰胆碱混合物(重量比25:75%)处理水解后的细胞骨架,恢复到对照水平。这些结果表明,除了先前已证明的含有因子Va外(15),细胞骨架凝血酶原酶复合物还含有部分由磷脂酰丝氨酸组成的脂质辅因子活性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验